Fabrizio Zucca

Fabrizio Zucca has a wealth of experience in market access and patient access roles within the pharmaceutical and healthcare industries. With a background in Health Economics, Fabrizio has held various leadership positions in companies such as Immedica Pharma AB, Alnylam Pharmaceuticals, Intercept Pharmaceuticals, Sobi - Swedish Orphan Biovitrum AB (publ), HGC GesundheitsConsult, and SHL Telemedizin. Their areas of expertise include market access, pricing and reimbursement, integrated care solutions, sales strategy, business development, health economic evaluations, and research access to health care data. Fabrizio Zucca is currently serving as the General Manager DACH at Immedica Pharma AB.